Second Heart Assist announced today that it completed the third in a planned series of studies for its mechanical circulatory support device. Whisper, a catheter-based, minimally invasive device, utilizes a stent cage fitted with a motorized impeller. It aids in providing circulatory support throughout a patient’s body. The system is intended for use in patients […]
Cardiac Implants
Anteris Technologies launches IPO to support heart valve technology
Anteris Technologies today announced the launch of its initial public offering in the U.S. The company aims to raise funds through the IPO to advance the development of its DurAVR transcatheter heart valve technology. Anteris’ IPO consists of 14.8 million shares of common stock, with an additional 2.22 million shares available to underwriters under a […]
Acutus Medical announces operational downsizing to solely support Medtronic distro deal
Acutus Medical announced a realignment of resources and operational downsizing resulting in a 70% workforce reduction. Dr. Shaden Marzouk, the company’s board chair, called the downsizing “hard but necessary steps” in a news release. The company intends to continue to comply with its remaining obligations to Medtronic for the production of left-heart access products. Acutus […]
Edwards projects 10% growth in first year as a purely structural heart company
Edwards Lifesciences (NYSE:EW) today announced its plans for significant growth as a purely structural heart company in 2025. The company is entering its first full year as a structural heart company following the $4.2 billion sale of its Critical Care business to BD. That sale was followed by a 3% global workforce reduction and a […]
Medtronic Evolut Pro TAVR demonstrates positive outcomes in study
Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement (TAVR) system. Findings included cusp overlap technique (COT) outcomes from the Optimize PRO clinical study and pooled analysis looking at Evolut Pro patients showing improvement in paravalvular leak (PVL) over time following hospital discharge. Investigators presented the new studies […]
BrioHealth begins enrollment in LVAD study
BrioHealth Solutions announced today that it enrolled its first patients in the U.S. for the INNOVATE trial of its BrioVAD system. Burlington, Massachusetts–based BrioHealth has had its BrioVAD technology under development since 2008. The left ventricular assist device (LVAD) features the BrioVAD pump, a fully magnetically suspended blood pump. It pairs with uniquely engineered external […]
Boston Scientific shares positive Acurate Prime XL TAVR data
Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime aortic valve system. Dr. Raj Makkar of Cedar-Sinai Medical Center presented data at PCR London Valves 2024. The 30-day outcomes came from the first combined dataset analysis evaluating the safety and efficacy of the Acurate prime aortic valve platform — exclusively […]
Abbott reports first cases with software-guided balloon-expandable TAVI
Abbott (NYSE:ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) system. The company designed its investigational software-guided, balloon-expandable TAVI system to build a foundation for AI-guided procedures. It hopes to add the expandable system to its structural heart portfolio alongside the already available Navitor TAVI system. Abbott designed its […]
Edwards reports ‘excellent’ outcomes for Sapien 3 Ultra Resilia TAVR system
Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia valve. Sapien 3 Ultra Resilia, a transcatheter aortic valve replacement (TAVR) system, incorporates the company’s Resilia tissue technology. Edwards designed the Resilia technology to extend the valve’s durability. It utilizes bovine pericardial tissue treated with anti-calcification technology, to serve […]
Supira begins early feasability study for percutaneous ventricular assist device
Supira Medical announced today that it began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate the pVAD in patients undergoing high-risk percutaneous coronary intervention (HRPCI). Los Gatos, California-based Supira’s study looks at the safety and feasibility of the low-profile, high-flow device. […]
Abbott reports positive Amplatzer Amulet data in head-to-head trial with Boston Scientific’s Watchman
Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system. The company presented data highlighting Amplatzer Amulet’s benefits in treating people with AFib at an increased risk of stroke. According to a news release, new five-year data demonstrates that the technology helps more patients avoid long-term use of blood-thinning medication […]
